These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23331664)

  • 1. High rates of transmitted drug resistance among newly-diagnosed antiretroviral naïve HIV patients in Northern Greece, data from 2009-2011.
    Skoura L; Metallidis S; Pilalas D; Kourelis A; Margariti A; Papadimitriou E; Antoniadou ZA; Chrysanthidis T; Tsachouridou O; Kollaras P; Nikolaidis P; Malisiovas N
    Clin Microbiol Infect; 2013 Mar; 19(3):E169-72. PubMed ID: 23331664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
    Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
    J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate levels of transmitted antiretroviral drug resistance in Midwestern Brazil.
    Pfrimer IA; Bizinoto MC; Brandão NA; Camargo M; Sucupira MC; Janini LM; Diaz RS
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):205-6. PubMed ID: 22978276
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.
    Paraskevis D; Magiorkinis E; Katsoulidou A; Hatzitheodorou E; Antoniadou A; Papadopoulos A; Poulakou G; Paparizos V; Botsi C; Stavrianeas N; Lelekis M; Chini M; Gargalianos P; Magafas N; Lazanas M; Chryssos G; Petrikkos G; Panos G; Kordossis T; Theodoridou M; Sypsa V; Hatzakis A;
    Virus Res; 2005 Sep; 112(1-2):115-22. PubMed ID: 16022906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.
    Carvalho BC; Cardoso LP; Damasceno S; Stefani MM
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular HIV type 1 DNA levels are equivalent among drug-sensitive and drug-resistant strains in newly diagnosed and antiretroviral naive patients.
    Antoniadou ZA; Hezka J; Kousiappa I; Mamais I; Skoura L; Pilalas D; Metallidis S; Nicolaidis P; Malisiovas N; Kostrikis LG
    AIDS Res Hum Retroviruses; 2014 Mar; 30(3):266-71. PubMed ID: 24025041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
    Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
    J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome.
    Jakobsen MR; Tolstrup M; Søgaard OS; Jørgensen LB; Gorry PR; Laursen A; Ostergaard L
    Clin Infect Dis; 2010 Feb; 50(4):566-73. PubMed ID: 20085464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras.
    Murillo W; Paz-Bailey G; Morales S; Monterroso E; Paredes M; Dobbs T; Parekh BS; Albert J; Rivera IL
    J Clin Virol; 2010 Dec; 49(4):239-44. PubMed ID: 20417152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
    Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
    J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antiretroviral drug resistance in antiretroviral-naive individuals.
    James CW; Moffett LE; Szabo S
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):193-5. PubMed ID: 19414829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent transmission of HIV-1 drug-resistant variants.
    Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L;
    Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa.
    Nwobegahay J; Selabe G; Ndjeka NO; Manhaeve C; Bessong PO
    J Med Virol; 2012 Dec; 84(12):1839-43. PubMed ID: 23080485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals.
    Fox J; Hill S; Kaye S; Dustan S; McClure M; Fidler S; Mackie NE
    AIDS; 2007 Jan; 21(2):237-9. PubMed ID: 17197816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected high rate of wild-type HIV-1 genotype among inmates failing antiretroviral therapy.
    Pontali E; Ventura A; Bruzzone B; Icardi G; Ferrari F
    HIV Clin Trials; 2008; 9(5):341-7. PubMed ID: 18977723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of transmitted HIV drug resistance in antiretroviral-naive patients aged less than 25 years, in Bangkok, Thailand.
    Sungkanuparph S; Pasomsub E; Chantratita W
    J Int Assoc Provid AIDS Care; 2014; 13(1):12-4. PubMed ID: 23708678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
    Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
    J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.